Utilizing Hindsight Following Progression of ADCs Into the Clinic
Time: 9:00 am
day: Conference Day One
Details:
- Target selection process and reasons behind the choice of pursuing various clinical targets
- Integrin β6 – an example of Seagen’s new and promising target showing early clinical success
- Considering reverse translation in the target selection process – lessons learned from the clinic
